CD8A and ovarian cancer: In primary ovarian cancers, CD83+ mature DCs, which are also known as DC-LAMPs, are predominantly localized in the T-cell zone of TA-TLSs and are correlated with CD8+ T-cell infiltration, antitumor cytotoxicity and survival (62, 98).